色素-话题@MedSci

#色素#

654篇内容 | 6337人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680727, encodeId=ded91680e2712, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Eur J Cancer：局部治疗在黑色素瘤免疫治疗出现孤立性转移时的作用：多中心回顾性研究, objectType=article, longId=211791, objectId=158a211e9126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=158a211e9126, replyNumber=0, likeNumber=77, createdTime=2021-07-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=158a211e9126, moduleTitle=Eur J Cancer：局部治疗在黑色素瘤免疫治疗出现孤立性转移时的作用：多中心回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=158a211e9126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680713, encodeId=b0ab1680e1366, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Cancer Res：联合抑制Gα和MEK可明显提高葡萄膜黑色素瘤的治疗效果, objectType=article, longId=206736, objectId=74dc206e362d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74dc206e362d, replyNumber=0, likeNumber=64, createdTime=2021-05-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74dc206e362d, moduleTitle=Clin Cancer Res：联合抑制Gα和MEK可明显提高葡萄膜黑色素瘤的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74dc206e362d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680729, encodeId=befe1680e297b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Brit J Cancer：运动、握力和久坐行为与恶性黑色素瘤发病率之间的关系, objectType=article, longId=212142, objectId=c2e121214201, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2e121214201, replyNumber=0, likeNumber=77, createdTime=2021-06-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2e121214201, moduleTitle=Brit J Cancer：运动、握力和久坐行为与恶性黑色素瘤发病率之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2e121214201)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680698, encodeId=fbea1680698bc, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=期刊速递丨辅助靶向治疗后黑色素瘤的复发模式和处理, objectType=article, longId=203179, objectId=fe162031e9b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe162031e9b7, replyNumber=0, likeNumber=26, createdTime=2021-06-23, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe162031e9b7, moduleTitle=期刊速递丨辅助靶向治疗后黑色素瘤的复发模式和处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe162031e9b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680686, encodeId=be61168068632, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=色素管型，那些重“色”的管型都是什么？, objectType=article, longId=199627, objectId=2e7a19962e6e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e7a19962e6e, replyNumber=0, likeNumber=60, createdTime=2020-12-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e7a19962e6e, moduleTitle=色素管型，那些重“色”的管型都是什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e7a19962e6e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680720, encodeId=c2531680e203a, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=黑色素瘤双靶、双适应症药物2020年医保价格正式实施，助益更多患者减轻负担, objectType=article, longId=208100, objectId=d0502081009c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0502081009c, replyNumber=0, likeNumber=80, createdTime=2021-11-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0502081009c, moduleTitle=黑色素瘤双靶、双适应症药物2020年医保价格正式实施，助益更多患者减轻负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0502081009c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680716, encodeId=8d241680e16c2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究, objectType=article, longId=207302, objectId=f64120e302ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f64120e302ed, replyNumber=0, likeNumber=145, createdTime=2021-03-13, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f64120e302ed, moduleTitle=Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f64120e302ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680697, encodeId=f09e168069e23, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nature：检测黑素细胞基因组，有望预测黑色素瘤风险, objectType=article, longId=202392, objectId=458e202392ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=458e202392ff, replyNumber=0, likeNumber=75, createdTime=2020-10-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=458e202392ff, moduleTitle=Nature：检测黑素细胞基因组，有望预测黑色素瘤风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=458e202392ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680682, encodeId=715e1680682c5, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Gastroenterology H: 因HFE突变引起的血色素沉着病患者行抗纤维化治疗后可降低肝癌发生风险, objectType=article, longId=198858, objectId=9ba819885848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ba819885848, replyNumber=0, likeNumber=79, createdTime=2021-07-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ba819885848, moduleTitle=Clin Gastroenterology H: 因HFE突变引起的血色素沉着病患者行抗纤维化治疗后可降低肝癌发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ba819885848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680684, encodeId=29ab1680684a7, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Ann Oncol：黑色素瘤新辅助治疗后pCR患者的组织病理学特征与无复发生存相关, objectType=article, longId=198987, objectId=cadf19898eaa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cadf19898eaa, replyNumber=0, likeNumber=147, createdTime=2020-11-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cadf19898eaa, moduleTitle=Ann Oncol：黑色素瘤新辅助治疗后pCR患者的组织病理学特征与无复发生存相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cadf19898eaa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680714, encodeId=943c1680e14d1, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=如何治疗PD-1难治性眼部黑色素瘤？抗CD40抗体YH003联合Toripalimab, objectType=article, longId=206768, objectId=a740206e6806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a740206e6806, replyNumber=0, likeNumber=58, createdTime=2021-12-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a740206e6806, moduleTitle=如何治疗PD-1难治性眼部黑色素瘤？抗CD40抗体YH003联合Toripalimab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a740206e6806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680667, encodeId=7769168066e72, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展, objectType=article, longId=193375, objectId=0f851933e5d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f851933e5d6, replyNumber=0, likeNumber=79, createdTime=2021-02-24, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f851933e5d6, moduleTitle=Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f851933e5d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680696, encodeId=145f168069631, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=X-连锁色素性视网膜炎（XLRP）基因疗法I/II期临床：显著改善视网膜敏感性, objectType=article, longId=201996, objectId=1f8e201996f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f8e201996f6, replyNumber=0, likeNumber=57, createdTime=2021-08-13, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f8e201996f6, moduleTitle=X-连锁色素性视网膜炎（XLRP）基因疗法I/II期临床：显著改善视网膜敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f8e201996f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680711, encodeId=af6f1680e11cf, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Eur J Cancer：BRAF和MEK抑制剂联合治疗亚洲晚期黑色素瘤患者的疗效, objectType=article, longId=206376, objectId=d9952063e6c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9952063e6c2, replyNumber=0, likeNumber=71, createdTime=2021-12-07, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9952063e6c2, moduleTitle=Eur J Cancer：BRAF和MEK抑制剂联合治疗亚洲晚期黑色素瘤患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9952063e6c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680719, encodeId=02451680e19d3, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Immunother Cancer：晚期黑色素瘤抗PD-1免疫治疗时的耐药类型和影像学变化, objectType=article, longId=207791, objectId=3b0c20e7910a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b0c20e7910a, replyNumber=0, likeNumber=109, createdTime=2021-05-27, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b0c20e7910a, moduleTitle=J Immunother Cancer：晚期黑色素瘤抗PD-1免疫治疗时的耐药类型和影像学变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b0c20e7910a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680676, encodeId=f1c616806e6ff, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=黑色素瘤癌症疫苗Seviprotimut-L，获得FDA快速通道认证, objectType=article, longId=196490, objectId=42171964903c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42171964903c, replyNumber=0, likeNumber=100, createdTime=2020-12-19, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42171964903c, moduleTitle=黑色素瘤癌症疫苗Seviprotimut-L，获得FDA快速通道认证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42171964903c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680663, encodeId=c70e1680663ac, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell Death Dis：自噬抑制可增强紫杉醇类似物Alteronol的黑色素瘤细胞上皮-间质转化进程, objectType=article, longId=192497, objectId=721519249ec0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=721519249ec0, replyNumber=0, likeNumber=68, createdTime=2020-05-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=721519249ec0, moduleTitle=Cell Death Dis：自噬抑制可增强紫杉醇类似物Alteronol的黑色素瘤细胞上皮-间质转化进程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=721519249ec0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680810, encodeId=cde9168081001, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Cancer Res：抗疟疾药氯喹可增加GNAQ/11突变性黑色素瘤对MEK1/2抑制剂的敏感性！, objectType=article, longId=200796, objectId=d03f200e96fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d03f200e96fe, replyNumber=0, likeNumber=148, createdTime=2021-01-19, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d03f200e96fe, moduleTitle=Clin Cancer Res：抗疟疾药氯喹可增加GNAQ/11突变性黑色素瘤对MEK1/2抑制剂的敏感性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d03f200e96fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680718, encodeId=bade1680e1878, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=J Clin Oncol：薄型(T1)黑色素瘤患者局部、区域和远处复发预测的新模型, objectType=article, longId=207580, objectId=77a120e5806e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77a120e5806e, replyNumber=0, likeNumber=72, createdTime=2022-02-10, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77a120e5806e, moduleTitle=J Clin Oncol：薄型(T1)黑色素瘤患者局部、区域和远处复发预测的新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77a120e5806e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680672, encodeId=5a6616806e284, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移, objectType=article, longId=194751, objectId=536d194e5107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=536d194e5107, replyNumber=0, likeNumber=134, createdTime=2020-08-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=536d194e5107, moduleTitle=NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=536d194e5107)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Eur J Cancer：局部治疗在黑色素瘤免疫治疗出现孤立性转移时的作用：多中心回顾性研究

2021-07-28

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Cancer Res：联合抑制Gα和MEK可明显提高葡萄膜黑色素瘤的治疗效果

2021-05-22

sunylz (审核中...)

前往app查看评论内容

#色素#

Brit J Cancer：运动、握力和久坐行为与恶性黑色素瘤发病率之间的关系

2021-06-26

sunylz (审核中...)

前往app查看评论内容

#色素#

期刊速递丨辅助靶向治疗后黑色素瘤的复发模式和处理

2021-06-23

sunylz (审核中...)

前往app查看评论内容

#色素#

色素管型，那些重“色”的管型都是什么？

2020-12-12

sunylz (审核中...)

前往app查看评论内容

#色素#

黑色素瘤双靶、双适应症药物2020年医保价格正式实施，助益更多患者减轻负担

2021-11-08

sunylz (审核中...)

前往app查看评论内容

#色素#

Nat Med：黑色素瘤新辅助疗法病理反应和生存率的汇总分析研究

2021-03-13

sunylz (审核中...)

前往app查看评论内容

#色素#

Nature：检测黑素细胞基因组，有望预测黑色素瘤风险

2020-10-31

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Gastroenterology H: 因HFE突变引起的血色素沉着病患者行抗纤维化治疗后可降低肝癌发生风险

2021-07-20

sunylz (审核中...)

前往app查看评论内容

#色素#

Ann Oncol：黑色素瘤新辅助治疗后pCR患者的组织病理学特征与无复发生存相关

2020-11-26

sunylz (审核中...)

前往app查看评论内容

#色素#

如何治疗PD-1难治性眼部黑色素瘤？抗CD40抗体YH003联合Toripalimab

2021-12-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell Death Dis：STAT3激活参与TLR4介导的黑色素瘤发生发展

2021-02-24

sunylz (审核中...)

前往app查看评论内容

#色素#

X-连锁色素性视网膜炎（XLRP）基因疗法I/II期临床：显著改善视网膜敏感性

2021-08-13

sunylz (审核中...)

前往app查看评论内容

#色素#

Eur J Cancer：BRAF和MEK抑制剂联合治疗亚洲晚期黑色素瘤患者的疗效

2021-12-07

sunylz (审核中...)

前往app查看评论内容

#色素#

J Immunother Cancer：晚期黑色素瘤抗PD-1免疫治疗时的耐药类型和影像学变化

2021-05-27

sunylz (审核中...)

前往app查看评论内容

#色素#

黑色素瘤癌症疫苗Seviprotimut-L，获得FDA快速通道认证

2020-12-19

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell Death Dis：自噬抑制可增强紫杉醇类似物Alteronol的黑色素瘤细胞上皮-间质转化进程

2020-05-16

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Cancer Res：抗疟疾药氯喹可增加GNAQ/11突变性黑色素瘤对MEK1/2抑制剂的敏感性！

2021-01-19

sunylz (审核中...)

前往app查看评论内容

#色素#

J Clin Oncol：薄型(T1)黑色素瘤患者局部、区域和远处复发预测的新模型

2022-02-10

sunylz (审核中...)

前往app查看评论内容

#色素#

NAT MED：阿尔兹海默症保护基因竟然促进黑色素瘤转移

2020-08-12

科室
- - 订阅+
  - 更多科室
工具
服务